Variant report

Variant	esv3359411
Chromosome Location	chr5:80255421-80257969
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:189)
CpG islands
(count:733)
Chromatin interactive
region (count:1)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:189 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:80255588-80256100	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr5:80255488-80255974	GM12878	blood:	n/a	n/a
3	BCL3	chr5:80255146-80256092	GM12878	blood:	n/a	n/a
4	CEBPB	chr5:80257643-80257958	IMR90	lung:	n/a	n/a
5	CEBPB	chr5:80257649-80257909	A549	lung:	n/a	n/a
6	CEBPB	chr5:80257653-80257965	HepG2	liver:	n/a	n/a
7	CHD1	chr5:80256711-80256898	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD1	chr5:80255766-80255951	H1-hESC	embryonic stem cell:	n/a	n/a
9	CREB1	chr5:80256401-80256642	A549	lung:	n/a	n/a
10	CREB1	chr5:80255584-80257085	HepG2	liver:	n/a	n/a
11	CTBP2	chr5:80255809-80257416	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr5:80256330-80256537	HepG2	liver:	n/a	n/a
13	CTCF	chr5:80256330-80256606	A549	lung:	n/a	n/a
14	CTCF	chr5:80256380-80256530	AG04450	lung:	n/a	n/a
15	CTCF	chr5:80256420-80256570	Caco-2	colon:	n/a	n/a
16	CTCF	chr5:80256400-80256550	GM12872	blood:	n/a	n/a
17	CTCF	chr5:80256241-80256615	HepG2	liver:	n/a	n/a
18	CTCF	chr5:80256425-80256471	Pancreas_OC	pancreas:	n/a	n/a
19	CTCF	chr5:80256640-80256790	HEK293	kidney:	n/a	n/a
20	CTCF	chr5:80256395-80256520	GM19240	blood:	n/a	n/a
21	CTCF	chr5:80256380-80256530	GM12873	blood:	n/a	n/a
22	CTCF	chr5:80256040-80256190	SAEC	small airway:	n/a	n/a
23	CTCF	chr5:80256360-80256510	NHDF-neo	bronchial:	n/a	n/a
24	CTCF	chr5:80256401-80256504	GM12892	blood:	n/a	n/a
25	CTCF	chr5:80256380-80256530	HCPEpiC	choroid plexus:	n/a	n/a
26	CTCF	chr5:80256388-80256490	GM13977	blood:	n/a	n/a
27	CTCF	chr5:80256333-80256586	GM12891	blood:	n/a	n/a
28	CTCF	chr5:80256680-80256830	AG04449	skin:	n/a	n/a
29	CTCF	chr5:80256840-80256990	WI-38	lung:	n/a	n/a
30	CTCF	chr5:80256360-80256510	SAEC	small airway:	n/a	n/a
31	CTCF	chr5:80256400-80256550	HA-sp	spinal cord:	n/a	n/a
32	CTCF	chr5:80256380-80256530	SK-N-SH_RA	brain:	n/a	n/a
33	CTCF	chr5:80256400-80256550	WERI-Rb-1	eye:	n/a	n/a
34	CTCF	chr5:80256767-80256768	A549	lung:	n/a	n/a
35	CTCF	chr5:80256391-80256503	H1-hESC	embryonic stem cell:	n/a	n/a
36	CTCF	chr5:80256360-80256510	A549	lung:	n/a	n/a
37	CTCF	chr5:80256600-80256750	GM12870	blood:	n/a	n/a
38	CTCF	chr5:80257140-80257290	AG04450	lung:	n/a	n/a
39	CTCF	chr5:80256400-80256550	HepG2	liver:	n/a	n/a
40	CTCF	chr5:80256800-80256950	GM12866	blood:	n/a	n/a
41	CTCF	chr5:80256480-80256630	HMEC	breast:	n/a	n/a
42	CTCF	chr5:80256377-80256527	HepG2	liver:	n/a	n/a
43	CTCF	chr5:80256620-80256770	GM12866	blood:	n/a	n/a
44	CTCF	chr5:80256285-80256655	IMR90	lung:	n/a	n/a
45	CTCF	chr5:80256380-80256530	AG09319	gingival:	n/a	n/a
46	CTCF	chr5:80256340-80256490	HRPEpiC	eye:	n/a	n/a
47	CTCF	chr5:80256342-80256484	SK-N-SH_RA	brain:	n/a	n/a
48	CTCF	chr5:80256380-80256530	GM12871	blood:	n/a	n/a
49	CTCF	chr5:80256320-80256470	AoAF	blood vessel:	n/a	n/a
50	CTCF	chr5:80256696-80256759	A549	lung:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:80256524-80256574	HIPEpiC	eye:	n/a
2	chr5:80256524-80256574	HIPEpiC	eye:	n/a
3	chr5:80256535-80256585	Jurkat	blood:	n/a
4	chr5:80257322-80257372	GM12891	blood:	n/a
5	chr5:80256371-80256421	PFSK-1	brain:	n/a
6	chr5:80255793-80255843	HRE	kidney:	n/a
7	chr5:80256971-80257021	U87	brain:	n/a
8	chr5:80256087-80256137	HepG2	liver:	n/a
9	chr5:80256371-80256421	AG10803	skin:	n/a
10	chr5:80256738-80256788	NB4	blood:	n/a
11	chr5:80256664-80256714	HIPEpiC	eye:	n/a
12	chr5:80256971-80257021	SAEC	small airway:	n/a
13	chr5:80256971-80257021	CMK	blood:	n/a
14	chr5:80257322-80257372	ECC-1	luminal epithelium:	n/a
15	chr5:80255793-80255843	BE2_C	brain:	n/a
16	chr5:80256371-80256421	HMEC	breast:	n/a
17	chr5:80257322-80257372	BJ	skin:	n/a
18	chr5:80257322-80257372	SK-N-SH	brain:	n/a
19	chr5:80256971-80257021	H1-hESC	embryonic stem cell:	embryo
20	chr5:80256166-80256216	HepG2	liver:	n/a
21	chr5:80257322-80257372	Hela-S3	cervix:	n/a
22	chr5:80256371-80256421	Caco-2	colon:	n/a
23	chr5:80256166-80256216	HPAEpiC	pulmonary alveolar:	n/a
24	chr5:80256137-80256187	T-47D	breast:	n/a
25	chr5:80256166-80256216	Hepatocyte	liver:	n/a
26	chr5:80256371-80256421	GM06990	blood:	n/a
27	chr5:80256738-80256788	GM12892	blood:	n/a
28	chr5:80257322-80257372	IMR90	lung:	fetal
29	chr5:80256971-80257021	SK-N-SH_RA	brain:	n/a
30	chr5:80256971-80257021	GM19239	blood:	n/a
31	chr5:80256087-80256137	NT2-D1	testis:	n/a
32	chr5:80257268-80257318	IMR90	lung:	fetal
33	chr5:80256166-80256216	HEEpiC	esophagus:	n/a
34	chr5:80257268-80257318	A549	lung:	n/a
35	chr5:80256524-80256574	CMK	blood:	n/a
36	chr5:80256664-80256714	HRPEpiC	eye:	n/a
37	chr5:80256524-80256574	SK-N-SH_RA	brain:	n/a
38	chr5:80256371-80256421	HRE	kidney:	n/a
39	chr5:80256738-80256788	HPAEpiC	pulmonary alveolar:	n/a
40	chr5:80256137-80256187	SAEC	small airway:	n/a
41	chr5:80256087-80256137	SK-N-SH_RA	brain:	n/a
42	chr5:80256971-80257021	AG04450	lung:	fetal
43	chr5:80257268-80257318	AG09309	skin:	n/a
44	chr5:80256971-80257021	ovcar-3	ovarian:	n/a
45	chr5:80256166-80256216	AoSMC	blood vessel:	n/a
46	chr5:80256137-80256187	HCPEpiC	choroid plexus:	n/a
47	chr5:80257268-80257318	AG10803	skin:	n/a
48	chr5:80256738-80256788	SAEC	small airway:	n/a
49	chr5:80256524-80256574	HCPEpiC	choroid plexus:	n/a
50	chr5:80256971-80257021	NB4	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:80257641..80260093-chr5:80260267..80261887,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHFR-2	chr5:80256600-80256726	NR_105015
2	lnc-DHFR-2	chr5:80256600-80256726	ENSG00000251450.1
3	lnc-DHFR-2	chr5:80256150-80256189	XLOC_004907

No data

Variant related genes	Relation type
RASGRF2	TF binding region
ENSG00000251450	TF binding region
RASGRF2	CpG island
ENSG00000251450	CpG island
CLSTN1	miRNA target sites

Extended variants
information (count: 103 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:103 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs143704828	chr5:80255428-80255429	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs573545755	chr5:80255433-80255434	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs5869061	chr5:80255434-80255435	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs377546672	chr5:80255436-80255437	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs112046963	chr5:80255437-80255438	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs58471792	chr5:80255439-80255440	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs58221500	chr5:80255444-80255445	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs143261947	chr5:80255565-80255566	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs574962773	chr5:80255577-80255578	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs182301880	chr5:80255610-80255611	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs142202596	chr5:80255621-80255622	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs75826925	chr5:80255674-80255675	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs551464047	chr5:80255683-80255684	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs578158374	chr5:80255720-80255721	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs543912726	chr5:80255741-80255742	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs139012661	chr5:80255743-80255744	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs563839572	chr5:80255744-80255745	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs555239792	chr5:80255770-80255771	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs573804736	chr5:80255772-80255773	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs529229831	chr5:80255777-80255778	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs143147197	chr5:80255819-80255820	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs186296592	chr5:80255843-80255844	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs147487537	chr5:80255845-80255846	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs150807893	chr5:80255867-80255868	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs368408704	chr5:80255868-80255869	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs551656564	chr5:80255879-80255880	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs571350593	chr5:80255885-80255886	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs530771170	chr5:80255903-80255904	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs115261645	chr5:80255974-80255975	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs567381181	chr5:80255996-80255997	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs536372664	chr5:80256053-80256054	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs552966695	chr5:80256066-80256067	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs566480555	chr5:80256163-80256164	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs535335752	chr5:80256164-80256165	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs113829217	chr5:80256270-80256271	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs113077126	chr5:80256294-80256295	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs139949554	chr5:80256299-80256300	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs557294649	chr5:80256312-80256313	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs73123076	chr5:80256339-80256340	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs542721215	chr5:80256380-80256381	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs553018509	chr5:80256410-80256411	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs559273802	chr5:80256422-80256423	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs375975609	chr5:80256443-80256444	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs368584906	chr5:80256484-80256485	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs374422363	chr5:80256507-80256508	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs199546647	chr5:80256594-80256595	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
47	rs114321099	chr5:80256596-80256597	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
48	rs188573830	chr5:80256614-80256615	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
49	rs373681724	chr5:80256623-80256624	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
50	rs377311539	chr5:80256626-80256627	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelofibrosis	22110671	CNVD
craniofacial dysmorphism	21918468	CNVD
lymphocytic leukemia	21291569	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD

Chromatin state (count:443 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:80251600-80255800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
2	chr5:80252400-80255600	Enhancers	Cortex derived primary cultured neurospheres	brain
3	chr5:80252400-80255600	Weak transcription	Ovary	ovary
4	chr5:80252800-80255600	Enhancers	Primary T helper naive cells from peripheral blood	blood
5	chr5:80253200-80255600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
6	chr5:80253200-80256000	Bivalent Enhancer	Fetal Thymus	thymus
7	chr5:80253400-80255800	Enhancers	Dnd41	blood
8	chr5:80253600-80255600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
9	chr5:80253600-80255600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
10	chr5:80254400-80255600	Enhancers	HepG2	liver
11	chr5:80254800-80255600	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
12	chr5:80254800-80255600	Bivalent Enhancer	Fetal Brain Male	brain
13	chr5:80255000-80255600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
14	chr5:80255000-80255800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
15	chr5:80255000-80256000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
16	chr5:80255000-80256000	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
17	chr5:80255200-80255600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr5:80255200-80255600	Bivalent/Poised TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr5:80255200-80255600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr5:80255200-80255600	Bivalent Enhancer	Brain Hippocampus Middle	brain
21	chr5:80255200-80255600	Bivalent Enhancer	Fetal Brain Female	brain
22	chr5:80255200-80255600	Bivalent Enhancer	Left Ventricle	heart
23	chr5:80255200-80255600	Enhancers	Right Atrium	heart
24	chr5:80255200-80255600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
25	chr5:80255200-80255600	Enhancers	NHLF	lung
26	chr5:80255200-80255800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
27	chr5:80255200-80255800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
28	chr5:80255200-80255800	Bivalent Enhancer	Thymus	Thymus
29	chr5:80255200-80256000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
30	chr5:80255200-80256000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr5:80255200-80256000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
32	chr5:80255200-80256000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
33	chr5:80255200-80256000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
34	chr5:80255200-80256600	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
35	chr5:80255400-80255600	Flanking Bivalent TSS/Enh	ES-WA7 Cell Line	embryonic stem cell
36	chr5:80255400-80255600	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr5:80255400-80255600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr5:80255400-80255600	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
39	chr5:80255400-80255600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
40	chr5:80255400-80255600	Flanking Bivalent TSS/Enh	Brain Anterior Caudate	brain
41	chr5:80255400-80255600	Flanking Bivalent TSS/Enh	Brain Cingulate Gyrus	brain
42	chr5:80255400-80255600	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
43	chr5:80255400-80255600	Bivalent/Poised TSS	Fetal Lung	lung
44	chr5:80255400-80255800	Transcr. at gene 5' and 3'	H9 Cell Line	embryonic stem cell
45	chr5:80255400-80255800	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr5:80255400-80255800	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
47	chr5:80255400-80255800	Flanking Active TSS	Brain Angular Gyrus	brain
48	chr5:80255400-80255800	Flanking Active TSS	Brain Substantia Nigra	brain
49	chr5:80255400-80255800	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
50	chr5:80255400-80255800	Bivalent Enhancer	Spleen	Spleen

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links